GB8812653D0 - Pharmaceutical composition based on high concentration esters of docosahexaenoic acid - Google Patents
Pharmaceutical composition based on high concentration esters of docosahexaenoic acidInfo
- Publication number
- GB8812653D0 GB8812653D0 GB888812653A GB8812653A GB8812653D0 GB 8812653 D0 GB8812653 D0 GB 8812653D0 GB 888812653 A GB888812653 A GB 888812653A GB 8812653 A GB8812653 A GB 8812653A GB 8812653 D0 GB8812653 D0 GB 8812653D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- pharmaceutical composition
- high concentration
- composition based
- docosahexaenoic acid
- esters
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8812653A GB2218904A (en) | 1988-05-27 | 1988-05-27 | Pharmaceutical composition based on high-concentration esters of docosahexaenoic acid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8812653A GB2218904A (en) | 1988-05-27 | 1988-05-27 | Pharmaceutical composition based on high-concentration esters of docosahexaenoic acid |
Publications (2)
Publication Number | Publication Date |
---|---|
GB8812653D0 true GB8812653D0 (en) | 1988-06-29 |
GB2218904A GB2218904A (en) | 1989-11-29 |
Family
ID=10637693
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB8812653A Withdrawn GB2218904A (en) | 1988-05-27 | 1988-05-27 | Pharmaceutical composition based on high-concentration esters of docosahexaenoic acid |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2218904A (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5436269A (en) * | 1991-11-14 | 1995-07-25 | Sagami Chemical Research Center | Method for treating hepatitis |
NL9201438A (en) * | 1992-08-11 | 1994-03-01 | Prospa Bv | Novel pharmaceutical compositions comprising esters of omega-3 polyunsaturated acids and their use in the topical treatment of ailments. |
FR2698269B1 (en) * | 1992-11-24 | 1995-01-06 | Inst Nat Sante Rech Med | New drugs based on unsaturated fatty acids, usable in particular as antiplatelet agents and / or as preferred transporters to the brain. |
IT1274734B (en) | 1994-08-25 | 1997-07-24 | Prospa Bv | PHARMACEUTICAL COMPOSITIONS CONTAINING POLYUNSATURATED FATTY ACIDS, THEIR ESTERS OR SALTS, WITH VITAMINS OR ANTIOXIDANT PROVITAMINS |
EP1886679A3 (en) * | 1995-06-07 | 2008-05-28 | Martek Biosciences Corporation | Methods for controlling highly unsaturated fatty acid content in various tissues |
US20030144219A1 (en) * | 2001-11-15 | 2003-07-31 | Phinney Stephen Dodge | Formulations and methods for treatment or amelioration of inflammatory conditions |
GB0210212D0 (en) * | 2002-05-03 | 2002-06-12 | Univ Southampton | Effects of dietary N-3 and N-6 pufa intake on atheromatous plaque stability |
US8729124B2 (en) | 2002-03-05 | 2014-05-20 | Pronova Biopharma Norge As | Use of EPA and DHA in secondary prevention |
NZ539624A (en) * | 2002-09-27 | 2008-08-29 | Martek Biosciences Corp | Prophylactic docosahexaenoic acid therapy for patients with subclinical inflammation |
CN1756545A (en) * | 2003-03-05 | 2006-04-05 | 索尔瓦药物有限公司 | Use of omega-3-fatty acids in the treatment of diabetic patients |
EP1466597A1 (en) * | 2003-04-07 | 2004-10-13 | Clinigenetics | Use of dha esters to control or prevent cardiovascular diseases |
WO2004091603A1 (en) * | 2003-04-07 | 2004-10-28 | Clinigenetics | Use of an ester of dha for the treatment of cardiovascular diseases |
ITMI20040069A1 (en) | 2004-01-21 | 2004-04-21 | Tiberio Bruzzese | USE OF HIGH CONCENTRATION N-3 FATTY ACID COMPOSITIONS FOR THE TREATMENT OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM |
GB0605900D0 (en) * | 2006-03-23 | 2006-05-03 | Lipigen As | Modulators of nuclear receptors |
US20100130608A1 (en) * | 2008-10-01 | 2010-05-27 | Martek Biosciences Corporation | Compositions and methods for reducing triglyceride levels |
CN109456395A (en) * | 2018-12-21 | 2019-03-12 | 南京财经大学 | A kind of incretin peptide and its application |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5735512A (en) * | 1980-06-27 | 1982-02-26 | Nippon Oil & Fats Co Ltd | Preventive and remedy for thrombosis |
GB2098065A (en) * | 1981-04-14 | 1982-11-17 | Nippon Suisan Kaisha Ltd | Antithrombotic compositions containing docosahexaenoic acid |
JPS59172416A (en) * | 1983-03-18 | 1984-09-29 | Terumo Corp | Fat transfusion solution |
FR2548021B1 (en) * | 1983-06-29 | 1986-02-28 | Dick P R | PROLONGED AND CONTINUOUS DERMAL PHARMACEUTICAL COMPOSITIONS BASED ON ESSENTIAL FATTY ACIDS |
-
1988
- 1988-05-27 GB GB8812653A patent/GB2218904A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
GB2218904A (en) | 1989-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL87079A0 (en) | Tetrahydrocarbazole 1-alkanoic acids and pharmaceutical compositions containing them | |
ZA854684B (en) | Long-chain alpha-omega-dicarboxylic acids and derivatives thereof and pharmaceutical compositions containing them | |
HU891084D0 (en) | Process for manufacturing of pharmaceutical compositions containing antiviricid and antibactericid fatty acids and monoglycerides | |
GB8812653D0 (en) | Pharmaceutical composition based on high concentration esters of docosahexaenoic acid | |
EP0196625A3 (en) | Resolution of racemic mixtures of aliphatic acid esters | |
IL78528A (en) | Difluoro-naphthyridine-and trifluoro-quinoline-carboxylic acids and esters and salts thereof and pharmaceutical compositions containing them | |
IL92545A0 (en) | Preparation of 2-chloropyridine-3-carboxylic acid esters | |
IL85969A0 (en) | Ribofuranuronic acid derivatives and pharmaceutical compositions containing them | |
NZ216971A (en) | Phosphonate esters and pharmaceutical compositions | |
IL78843A0 (en) | Thiazolidine carboxylic acid derivatives and pharmaceutical and cosmetic compositions containing them | |
HUT40639A (en) | Process for producing quinolon-carboxylic acid derivative and pharmaceutical composition containing them | |
NZ212388A (en) | Deglucoteicoplanin carboxylic acid ester derivatives and pharmaceutical compositions | |
HUT50112A (en) | Process for producing phenoxyalkyl-carboxylic acid derivatives and pharmaceutical compositions containing them as active component | |
PT82339A (en) | Process for the preparation of novel androstane-17beta-carboxylic acid esters and of pharmaceutical compositions containing the same | |
PT82436A (en) | Process for the preparation of 7-amino-3-propenylcephalosporanic acid and esters thereof | |
PT82836A (en) | Process for the preparation of 3-(substituted)-propenylaminothiazolylcephalosporanic acids and esters thereof and of pharmaceutical compositions containing the same | |
IL88403A0 (en) | Esters of pharmacologically active carboxylic acids,their manufacture and pharmaceutical compositions containing them | |
NZ224923A (en) | 2-methoxymethyl-penem-3-carboxylic acid derivatives and pharmaceutical compositions | |
IL84724A0 (en) | Substituted aminomethyl-5,6,7,8-tetrahydronaphthyloxyacetic acids and esters and amides thereof,their preparation and pharmaceutical compositions containing them | |
PT86776A (en) | PROCESS FOR THE PREPARATION OF PIPERAZINECARBOXYLIC ACID AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT | |
HU895952D0 (en) | Process for the preparation of substituted pyrrolidone-2-carboxylic acid derivatives and pharmaceutical compositions containing them | |
EP0191735A3 (en) | Novel oxaluric acid derivatives and pharmaceutical compositions containing them | |
NZ217724A (en) | Esters of dihydrolysergic acid and pharmaceutical composition | |
NZ218614A (en) | 16,17-butylidenedioxy-6,9-difluoro-11-hydroxy-3, 20-dioxopregna-1,4-diene-21-oic acid esters and pharmaceutical compositions | |
IL79947A (en) | 4-alkoxy-3-pyrrolin-2-on-1-yl acetic acid esters and process for their preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |